Scotia Capital’s Quest Diagnostics DGX Stock Holding History

Scotia Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,555	Closed	-$788K	–	897
2021 Q4	$788K	Sell	4,555 -762	-14%	-$116K	0.01%	561
2021 Q3	$773K	Sell	5,317 -1,296	-20%	-$190K	0.01%	553
2021 Q2	$873K	Sell	6,613 -5	-0.1%	-$655	0.01%	537
2021 Q1	$849K	Buy	+6,618	New	+$815K	0.01%	521
2018 Q4	–	Sell	-3,150	Closed	-$340K	–	672
2018 Q3	$340K	Buy	+3,150	New	+$345K	﹤0.01%	593

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Scotia Capital's DGX Position: Q1 2022 in Review

Scotia Capital sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 4,555 shares — an estimated $788K sold.

Scotia Capital first reported a position in DGX in Q3 2018 and held it in 5 quarters. The position peaked at $873K in Q2 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

Scotia Capital reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
Scotia Capital sold 4,555 Quest Diagnostics shares in Q1 2022, an estimated $788K.
Scotia Capital first reported a position in Quest Diagnostics in Q3 2018 and held it in 5 quarters.
Scotia Capital's Quest Diagnostics position peaked at $873K in Q2 2021.
851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Scotia Capital's 13F filing for Q1 2022, filed 9 May 2022.